WHO backs dolutegravir, injectables in new HIV care guidance
Health and Wellness
WHO backs dolutegravir, injectables in new HIV care guidance
WHO has updated its HIV guidelines, reaffirming dolutegravir, backing long-acting injectables, revising protease inhibitor choices and TB prevention, aiming to improve outcomes and advance efforts to end AIDS.
By David Abonyo